The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Paediatric pharmacokinetics: key considerations
Open accessAbstract
A number of anatomical and physiological factors determine the pharmacokinetic profile of a drug. Differences in physiology in paediatric populations compared with adults can influence the concentration of drug within the plasma or tissue. Healthcare professionals need to be aware of anatomical and physiological changes that affect pharmacokinetic profiles of drugs to understand consequences of dose adjustments in infants and children. Pharmacokinetic clinical trials in children are complicated owing to the limitations on blood sample volumes and perception of pain in children resulting from blood sampling. There are alternative sampling techniques that can minimize the invasive nature of such trials. Population based models can also limit the sampling required from each individual by increasing the overall sample size to generate robust pharmacokinetic data. This review details key considerations in the design and development of paediatric pharmacokinetic clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development of the Human Infant Intestinal Microbiota
Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A., & Brown, P. O. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050177 · Cited by 2,877
Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes
Kurokawa, K., Itoh, T., Kuwahara, T., Oshima, K., Toh, H., Toyoda, A., Takami, H., Morita, H., Sharma, V. K., Srivastava, T. P., et al. (2007) · DNA Research · doi:10.1093/dnares/dsm018 · Cited by 869
Paine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., & Thummel, K. E. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37149-6 · Cited by 789
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Development of intestinal microbiota in infants and its impact on health
Matamoros, S., Gras-Leguen, C., Le Vacon, F., Potel, G., & de La Cochetiere, M.-F. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2012.12.001 · Cited by 534
Johnson, T. N., Rostami-Hodjegan, A., & Tucker, G. T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645090-00005 · Cited by 530
Clinical Pharmacokinetics of Levetiracetam
Patsalos, P. N. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443110-00002 · Cited by 473
Barter, Z., Bayliss, M., Beaune, P., Boobis, A., Carlile, D., Edwards, R., Brian Houston, J., Lake, B., Lipscomb, J., Pelkonen, O., et al. (2007) · Current Drug Metabolism · doi:10.2174/138920007779315053 · Cited by 459
STOLTZ, M., REYNOLDS, D., ELKINS, L., SALAZAR, D., & Weir, S. J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90252-x · Cited by 440
First-pass metabolism of cyclosporin by the gut
Kolars, J. C., Watkins, P. B., Merion, R. M., & Awni, W. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)92302-i · Cited by 422
Bartelink, I. H., Rademaker, C. M. A., Schobben, A. F. A. M., & van den Anker, J. N. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645110-00003 · Cited by 418
First-pass metabolism of midazolam by the human intestine*
Paine, M. F., Shen, D. D., Kunze, K. L., Perkins, J. D., Marsh, C. L., McVicar, J. P., Barr, D., Gillies, B. S., & Thummel, K. E. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90162-9b · Cited by 418
The ontogeny of drug metabolism enzymes and implications for adverse drug events
Hines, R. N. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.005 · Cited by 410
Development of the human gastrointestinal tract. A review.
Grand, R. J., Watkins, J. B., & Torti, F. M. (1976) · PubMed · Cited by 408
Morselli, P. L., Franco-Morselli, R., & Bossi, L. (1980) · Clinical Pharmacokinetics · doi:10.2165/00003088-198005060-00001 · Cited by 387
Development of the Human Gastrointestinal Tract
Grand, R. J., Watkins, J. B., & Torti, F. M. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80277-6 · Cited by 385
McCarver, D. G., & Hines, R. N. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.361 · Cited by 366
The Ontogeny of Human Drug-Metabolizing Enzymes: Phase I Oxidative Enzymes
Hines, R. N., & McCarver, D. G. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.355 · Cited by 365
Weiss, C. F., Glazko, A. J., & Weston, J. K. (1960) · New England Journal of Medicine · doi:10.1056/nejm196004212621601 · Cited by 352
Ginsberg, G. (2002) · Toxicological Sciences · doi:10.1093/toxsci/66.2.185 · Cited by 332
Developmental Expression of Human Hepatic CYP2C9 and CYP2C19
Koukouritaki, S. B., Manro, J. R., Marsh, S. A., Stevens, J. C., Rettie, A. E., McCarver, D. G., & Hines, R. N. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060137 · Cited by 325
Age differences in drug binding by plasma proteins: Studies on human foetuses, neonates and adults
Ehrnebo, M., Agurell, S., Jalling, B., & Bor�us, L. O. (1971) · European Journal of Clinical Pharmacology · doi:10.1007/bf00565004 · Cited by 269
Intestinal permeability in the newborn.
Weaver, L. T., Laker, M. F., & Nelson, R. (1984) · Archives of Disease in Childhood · doi:10.1136/adc.59.3.236 · Cited by 227
Oral Drug Absorption: Prediction and Assessment
Dressman, J., & Lennernäs, H. (2000) · Medical Entomology and Zoology · Cited by 217
The role of population PK–PD modelling in paediatric clinical research
De Cock, R. F. W., Piana, C., Krekels, E. H. J., Danhof, M., Allegaert, K., & Knibbe, C. A. J. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0782-9 · Cited by 215
Ontogeny of drug metabolizing enzymes in the neonate
Blake, M. J., Castro, L., Leeder, J. S., & Kearns, G. L. (2005) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2004.11.001 · Cited by 204
Understanding dosing: children are small adults, neonates are immature children
Anderson, B. J., & Holford, N. H. G. (2013) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-303720 · Cited by 197
Facilitation of Drug Evaluation in Children by Population Methods and Modelling†
Tod, M., Jullien, V., & Pons, G. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847040-00002 · Cited by 194
Physiologically Based Pharmacokinetic (PBPK) Modeling in Children
Barrett, J. S., Della Casa Alberighi, O., Läer, S., & Meibohm, B. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.64 · Cited by 182
Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum
Moreno, M. P. D. L. C., Oth, M., Deferme, S., Lammert, F., Tack, J., Dressman, J., & Augustijns, P. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.8.0009 · Cited by 180
The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
Holtbecker, N., Fromm, M. F., Kroemer, H. K., Ohnhaus, E. E., & Heidemann, H. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08415-6 · Cited by 178
Predicting human intestinal permeability using single-pass intestinal perfusion in rat.
Zakeri‐Milani, P., Valizadeh, H., Tajerzadeh, H., Azarmi, Y., Islambolchilar, Z., Barzegar, S., & Barzegar-Jalali, M. (2007) · PubMed · Cited by 177
Clinical Pharmacokinetics in Neonates
Morselli, P. L. (1976) · Clinical Pharmacokinetics · doi:10.2165/00003088-197601020-00001 · Cited by 173
Intestinal permeability in relation to birth weight and gestational and postnatal age
van Elburg, R. M., Fetter, W. P. F., Bunkers, C. M., & Heymans, H. S. A. (2003) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.88.1.f52 · Cited by 170
Improving Pediatric Dosing Through Pediatric Initiatives: What We Have Learned
Rodriguez, W., Selen, A., Avant, D., Chaurasia, C., Crescenzi, T., Gieser, G., Di Giacinto, J., Huang, S.-M., Lee, P., Mathis, L., et al. (2008) · Pediatrics · doi:10.1542/peds.2007-1529 · Cited by 161
The problems in scaling adult drug doses to children
Johnson, T. N. (2008) · Archives of Disease in Childhood · doi:10.1136/adc.2006.114835 · Cited by 159
Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
Edginton, A. N., Theil, F., Schmitt, W., & Willmann, S. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.9.1143 · Cited by 159
Johnson, T. N., Tanner, M. S., Taylor, C. J., & Tucker, G. T. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01370.x · Cited by 156
Khalil, F., & Läer, S. (2011) · BioMed Research International · doi:10.1155/2011/907461 · Cited by 155
LOCALIZATION AND mRNA EXPRESSION OF CYP3A AND P-GLYCOPROTEIN IN HUMAN DUODENUM AS A FUNCTION OF AGE
Fakhoury, M., Litalien, C., Médard, Y., Cavé, H., Ezzahir, N., Peuchmaur, M. M., & Jacqz-Aigrain, É. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005611 · Cited by 155
Benedetti, M. S., Whomsley, R., & Baltes, E. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.3.447 · Cited by 155
Pediatric Versus Adult Drug Trials for Conditions With High Pediatric Disease Burden
Bourgeois, F. T., Murthy, S., Pinto, C., Olson, K. L., Ioannidis, J. P. A., & Mandl, K. D. (2012) · PEDIATRICS · doi:10.1542/peds.2012-0139 · Cited by 149
Effect of a Cola Beverage on the Bioavailability of Itraconazole in the Presence of H2 Blockers
Lange, D., Pavao, J. H., Wu, J., & Klausner, M. A. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04332.x · Cited by 136
Ontogeny of drug elimination by the human kidney
Chen, N., Aleksa, K., Woodland, C. L. A., Rieder, M. J., & Koren, G. (2005) · Pediatric Nephrology · doi:10.1007/s00467-005-2105-4 · Cited by 129
Boucher, F. D., Modlin, J. F., Weller, S., Ruff, A., Mirochnick, M. H., Pelton, S. I., Wilfert, C. M., McKinney, R. E., Crain, M. J., Elkins, M., et al. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83507-3 · Cited by 111
Huang, N. Ν., & High, R. H. (1953) · The Journal of Pediatrics · doi:10.1016/s0022-3476(53)80422-1 · Cited by 109
Pharmacokinetics in the infant.
Milsap, R. L., & Jusko, W. J. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102s11107 · Cited by 108
Pharmacokinetics and metabolism of oral midazolam in preterm infants
de Wildt, S. N., Kearns, G. L., Hop, W. C. J., Murry, D. J., Abdel‐Rahman, S. M., & van den Anker, J. N. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01223.x · Cited by 106
Enteral absorption and bioavailability in children in relation to age
Heimann, G. (1980) · European Journal of Clinical Pharmacology · doi:10.1007/bf00561477 · Cited by 106
von Richter, O., Greiner, B., Fromm, M. F., FRASER, R., Omari, T. I., Barclay, M. L., Dent, J., Somogyi, A. A., & Eichelbaum, M. F. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117937 · Cited by 91
Ontogeny of oral drug absorption processes in children
Mooij, M. G., de Koning, B. A., Huijsman, M. L., & de Wildt, S. N. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.698261 · Cited by 88
de Wildt, S. N. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.577739 · Cited by 83
Intestinal Metabolism and Transport of Drugs in Children: The Effects of Age and Disease
Johnson, T. N., & Thomson, M. A. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31816a8cca · Cited by 82
Drug metabolism in the paediatric population and in the elderly
Benedetti, M. S., Whomsley, R., & Canning, M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.011 · Cited by 81
Neonatal Population Pharmacokinetics of Phénobarbital Derived from Routine Clinical Data
Grasela, T. H., & Donn, S. M. (2017) · Developmental Pharmacology and Therapeutics · doi:10.1159/000457062 · Cited by 80
Strougo, A., Eißing, T., Yassen, A., Willmann, S., Danhof, M., & Freijer, J. I. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9241-9 · Cited by 64
Kalach, N., Rocchiccioli, F., Boissieu, D. D., Benhamou, P., & Dupont, C. M. (2001) · Acta Paediatrica · doi:10.1111/j.1651-2227.2001.tb00788.x · Cited by 64
Krekels, E. H. J., van Hasselt, J. G. C., Tibboel, D., Danhof, M., & Knibbe, C. A. J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0333-1 · Cited by 60
Al-Obaidy, S. S., Po, A. L. W., McKiernan, P. J., Glasgow, J. F. T., & Millership, J. S. (1995) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/0731-7085(95)01303-3 · Cited by 50
Digoxin Inactivation by the Gut Flora in Infancy and Childhood
Linday, L. A., Dobkin, J. F., Wang, T. C., Butler, V. P., Saha, J. R., & Lindenbaum, J. (1987) · PEDIATRICS · doi:10.1542/peds.79.4.544 · Cited by 48
Pharmacokinetics and Pharmacodynamics in the Critically Ill Child
Zuppa, A. F., & Barrett, J. S. (2008) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2008.02.017 · Cited by 45
Innovative study design for paediatric clinical trials
on behalf of the TEDDY Network of Excellence, Baiardi, P., Giaquinto, C., Girotto, S., Manfredi, C., & Ceci, A. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-0990-y · Cited by 42
Using ontogeny information to build predictive models for drug elimination
Alcorn, J., & McNamara, P. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.03.016 · Cited by 31
Andrieux, C., Membré, J., Cayuela, C., & Antoine, J. M. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/gas.37.7.792.798 · Cited by 29
Zughaid, H., Forbes, B., Martin, G. P., & Patel, N. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.11.012 · Cited by 18
Pharmacokinetic research in children: an analysis of registered records of clinical trials
Viergever, R. F., Rademaker, C. M. A., & Ghersi, D. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000221 · Cited by 18
Unerwünschte Wachheit: Ein Problem auch in der Kinderanästhesie?
Jöhr, M. (2006) · Der Anaesthesist · doi:10.1007/s00101-006-1040-5 · Cited by 11
Pharmacokinetics and Pharmacodynamics of Oseltamivir in Neonates, Infants and Children
Standing, J. F., Tsolia, M. N., & Lutsar, I. (2013) · Infectious Disorders - Drug Targets · doi:10.2174/18715265112129990003 · Cited by 8
Cited by
Management of functional constipation in children and adults
Vriesman, M. H., Koppen, I. J. N., Camilleri, M., Di Lorenzo, C., & Benninga, M. A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0222-y · Cited by 457
Developmental Changes in Pharmacokinetics and Pharmacodynamics
van den Anker, J., Reed, M. D., Allegaert, K., & Kearns, G. L. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1284 · Cited by 389
Waller, D. G., & Sampson, A. P. (2018) · Medical Pharmacology and Therapeutics · doi:10.1016/b978-0-7020-7167-6.00002-6 · Cited by 23
Ratier, A., Casas, M., Grazuleviciene, R., Slama, R., Småstuen Haug, L., Thomsen, C., Vafeiadi, M., Wright, J., Zeman, F. A., Vrijheid, M., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108621 · Cited by 16
Janssen, J. M., Zwaan, C. M., Schellens, J. H. M., Beijnen, J. H., & Huitema, A. D. R. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.07.050 · Cited by 6
Metadata
- Authors
- Batchelor, H. K., & Marriott, J. F.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2015-02-20
- Volume
- 79
- Issue
- 3
- Pages
- 395-404
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W1517020700
- Cited by
- 355
- References
- 68
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.